According to FutureWise analysis the market for anti-infective vaccines in 2023 is US$ 64.57 billion, and is expected to reach US$ 165.91 billion by 2031 at a CAGR of 12.50%.
Anti-infective vaccines, also known as infectious disease vaccines, are medical interventions developed to prevent the spread of infectious diseases caused by specific microorganisms such as bacteria, viruses, parasites, or others. These vaccines boost the immune system to produce an immune response without causing the disease, resulting in immunity against the targeted infectious agent, and are one of the most cost-effective investments in health and economic development. Immunization can prevent suffering and death from infectious diseases like polio, measles, and pneumonia. In 1796, Edward Jenner invented the first vaccine using cowpox to inoculate against smallpox. His groundbreaking work ultimately led to the global eradication of smallpox, officially declared in 1980. Since then, vaccines have helped to suppress the spread of several infectious diseases, including polio.
Live attenuated vaccines contain complete viruses or bacteria that have been deliberately weakened (attenuated) to elicit an immune response without causing illness in healthy individuals. For most modern vaccines, this "weakening" is acquired through genetic modification of the pathogen, either through naturally occurring change or as an alteration introduced by scientists. These vaccines are known for inducing robust and long-lasting immune responses, making them among the most effective options available. However, live vaccines may not be suitable for individuals whose immune system doesn't work due to drug treatment or underlying health conditions. This is because the weakened pathogens could potentially reproduce excessively and lead to illness in these individuals.
FutureWise Market Research has published a report that provides an insightful analysis anti-infective vaccines market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, anti-infective vaccines market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.